中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2013年
5期
336-340
,共5页
张旻%肖新强%刘素芳%梁云生%彭米林%许允%龚国忠
張旻%肖新彊%劉素芳%樑雲生%彭米林%許允%龔國忠
장민%초신강%류소방%량운생%팽미림%허윤%공국충
肝炎,乙型%转录启动子%程序性死亡受体-1
肝炎,乙型%轉錄啟動子%程序性死亡受體-1
간염,을형%전록계동자%정서성사망수체-1
Hepatitis B%Transcription initiation site%Programmed death 1
目的 探讨慢性乙型肝炎(CHB)患者外周血单个核细胞(PBMCs)上程序性死亡受体-1(PD-1)表达和PD-1启动子区域甲基化水平的差异及其影响因素,以及两者之间的关系.方法 筛选2009年9月至2011年9月在中南大学湘雅二医院传染科门诊就诊144例CHB患者和18名健康献血员,流式细胞术(FCM)检测PBMCs表面表达PD-1的细胞比例,同时进行肝功能检测;时间分辨荧光免疫分析法检测CHB患者血清HBV标志物水平,荧光定量PCR检测血清HBV DNA载量;亚硫酸氢钠处理PBMCs细胞DNA,PCR扩增PD-1启动子基因片段,转化感受态大肠杆菌,挑克隆测序,检测扩增的PD-1启动子片段甲基化状态.结果 与正常对照组(10.8%±4.4%)比较,CHB患者PBMCs上PD-1表达水平明显升高.在CHB患者中,PBMCs上PD-1表达在HBeAg阳性患者(27.1%±18.4%)中显著高于HBeAg阴性患者(19.6%±15.6%),PD-1表达水平与HBV-DNA和ALT水平无明显相关性.PD-1启动子上多个CpG点(-601、-553、-538、-483、-463、-317 bp)甲基化程度与PD-1在单个核细胞上的表达呈负相关.结论 PD-1基因启动子区域甲基化水平可能影响CHB患者PBMCs上PD-1表达.
目的 探討慢性乙型肝炎(CHB)患者外週血單箇覈細胞(PBMCs)上程序性死亡受體-1(PD-1)錶達和PD-1啟動子區域甲基化水平的差異及其影響因素,以及兩者之間的關繫.方法 篩選2009年9月至2011年9月在中南大學湘雅二醫院傳染科門診就診144例CHB患者和18名健康獻血員,流式細胞術(FCM)檢測PBMCs錶麵錶達PD-1的細胞比例,同時進行肝功能檢測;時間分辨熒光免疫分析法檢測CHB患者血清HBV標誌物水平,熒光定量PCR檢測血清HBV DNA載量;亞硫痠氫鈉處理PBMCs細胞DNA,PCR擴增PD-1啟動子基因片段,轉化感受態大腸桿菌,挑剋隆測序,檢測擴增的PD-1啟動子片段甲基化狀態.結果 與正常對照組(10.8%±4.4%)比較,CHB患者PBMCs上PD-1錶達水平明顯升高.在CHB患者中,PBMCs上PD-1錶達在HBeAg暘性患者(27.1%±18.4%)中顯著高于HBeAg陰性患者(19.6%±15.6%),PD-1錶達水平與HBV-DNA和ALT水平無明顯相關性.PD-1啟動子上多箇CpG點(-601、-553、-538、-483、-463、-317 bp)甲基化程度與PD-1在單箇覈細胞上的錶達呈負相關.結論 PD-1基因啟動子區域甲基化水平可能影響CHB患者PBMCs上PD-1錶達.
목적 탐토만성을형간염(CHB)환자외주혈단개핵세포(PBMCs)상정서성사망수체-1(PD-1)표체화PD-1계동자구역갑기화수평적차이급기영향인소,이급량자지간적관계.방법 사선2009년9월지2011년9월재중남대학상아이의원전염과문진취진144례CHB환자화18명건강헌혈원,류식세포술(FCM)검측PBMCs표면표체PD-1적세포비례,동시진행간공능검측;시간분변형광면역분석법검측CHB환자혈청HBV표지물수평,형광정량PCR검측혈청HBV DNA재량;아류산경납처리PBMCs세포DNA,PCR확증PD-1계동자기인편단,전화감수태대장간균,도극륭측서,검측확증적PD-1계동자편단갑기화상태.결과 여정상대조조(10.8%±4.4%)비교,CHB환자PBMCs상PD-1표체수평명현승고.재CHB환자중,PBMCs상PD-1표체재HBeAg양성환자(27.1%±18.4%)중현저고우HBeAg음성환자(19.6%±15.6%),PD-1표체수평여HBV-DNA화ALT수평무명현상관성.PD-1계동자상다개CpG점(-601、-553、-538、-483、-463、-317 bp)갑기화정도여PD-1재단개핵세포상적표체정부상관.결론 PD-1기인계동자구역갑기화수평가능영향CHB환자PBMCs상PD-1표체.
Objective To observe the expression variations and influencing factors of programmed death one (PD-1) and DNA demethylation of PD-1 promoter on peripheral blood mononuclear cells (PBMCs) in chronic hepatitis B (CHB) patients and further investigate the relationship between the demethylation pattern of PD-1 gene in promoter region and the PD-1 expression on PBMC in CHB patients.Methods A total of 162 subjects,including 144 CHB patients and 18 healthy blood donors,were enrolled.The expression of PD-1 on PBMCs was detected by flow cytometry.And the serum HBV markers,HBV DNA load and liver function were also measured.DNA of PBMCs was treated with sodium bisulfite; the PD-1 promoter fragments were amplified by polymerase chain reaction (PCR) and then transformed into Escherichia coli.Positive clones were selected for sequencing and the methylation status of fragments of PD-1 promoter was examined.Results With the PD-1 expression in normal controls (10.8% ± 4.4%) as a baseline level,the expression of PD-1 in CHB patients significantly increased.In CHB patients,the serum expression of PD-lin PBMCs from patients with positive HBeAg (27.1% ± 18.4%) was much higher than that from those with negative HBeAg (19.6% ± 15.6%).And the expression level of PD-1 was not correlated with serum HBV DNA load and serum level of alanine aminotransferase.The results of bisulfite genomic sequencing showed that demethylation probability of some CG points in PD-1 promoter region (-601,-553,-538,-483,-463,-317 bp) were significantly correlated with PD-1 expression level (P < 0.05).Conclusion The demethylation pattern of PD-1 gene in promoter region is associated with the PD-1 expression on PBMC in CHB patients.